[go: up one dir, main page]

NO20050132D0 - Vaksinesammensetning - Google Patents

Vaksinesammensetning

Info

Publication number
NO20050132D0
NO20050132D0 NO20050132A NO20050132A NO20050132D0 NO 20050132 D0 NO20050132 D0 NO 20050132D0 NO 20050132 A NO20050132 A NO 20050132A NO 20050132 A NO20050132 A NO 20050132A NO 20050132 D0 NO20050132 D0 NO 20050132D0
Authority
NO
Norway
Prior art keywords
vaccine composition
vaccine
composition
Prior art date
Application number
NO20050132A
Other languages
English (en)
Other versions
NO20050132L (no
Inventor
Pierre Michel Desmons
Jan Poolman
Ramon Faustino Barbera Morales
Francisco Jesus Doming Alvarez
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of NO20050132D0 publication Critical patent/NO20050132D0/no
Publication of NO20050132L publication Critical patent/NO20050132L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20050132A 2002-06-13 2005-01-11 Vaksinesammensetning som omfatter blanding av multivalente meningokokk yttermembran vesikler NO20050132L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0213622.4A GB0213622D0 (en) 2002-06-13 2002-06-13 Vaccine Corporation
PCT/EP2003/006094 WO2003105890A2 (en) 2002-06-13 2003-06-10 Vaccine composition

Publications (2)

Publication Number Publication Date
NO20050132D0 true NO20050132D0 (no) 2005-01-11
NO20050132L NO20050132L (no) 2005-02-11

Family

ID=9938532

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050132A NO20050132L (no) 2002-06-13 2005-01-11 Vaksinesammensetning som omfatter blanding av multivalente meningokokk yttermembran vesikler

Country Status (20)

Country Link
US (1) US20060110412A1 (no)
EP (1) EP1565211A2 (no)
JP (1) JP2005531614A (no)
KR (1) KR20050049431A (no)
CN (1) CN100387298C (no)
AR (1) AR040204A1 (no)
AU (1) AU2003236734A1 (no)
BR (1) BR0311777A (no)
CA (1) CA2488782A1 (no)
CL (1) CL2003001192A1 (no)
CU (1) CU23552A1 (no)
GB (1) GB0213622D0 (no)
MX (1) MXPA04012568A (no)
NO (1) NO20050132L (no)
NZ (1) NZ560766A (no)
PE (1) PE20040562A1 (no)
RU (1) RU2005100509A (no)
UY (1) UY27843A1 (no)
WO (1) WO2003105890A2 (no)
ZA (1) ZA200409547B (no)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1322328B1 (en) 2000-07-27 2014-08-20 Children's Hospital & Research Center at Oakland Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis
GB2414667A (en) * 2004-06-03 2005-12-07 Isis Innovation Vaccine compositions of N. meningitidis PorA and FetA antigens
GB0419627D0 (en) * 2004-09-03 2004-10-06 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
CN101107007B (zh) 2005-01-27 2011-08-17 奥克兰儿童医院及研究中心 对脑膜炎奈瑟球菌所致疾病具有广谱保护作用的gna1870囊泡疫苗
KR101441368B1 (ko) * 2005-12-22 2014-09-24 글락소스미스클라인 바이오로지칼즈 에스.에이. 폐렴구균 다당류 컨쥬게이트 백신
US8956625B2 (en) 2006-09-07 2015-02-17 Glaxosmithkline Biologicals, S.A. Inactivated polio vaccines
BR122016015627A2 (pt) 2007-10-19 2018-10-30 Novartis Ag kit, composição antigênica liofilizada e método para preparação de uma composição imunogênica
WO2009062132A2 (en) 2007-11-09 2009-05-14 California Institute Of Technology Immunomodulating compounds and related compositions and methods
BRPI0907010A2 (pt) * 2008-02-01 2015-07-07 Sanofi Pasteur Ltd Análise para o diagnóstico de streptococcus pneumoniae
CA2716706C (en) 2008-03-03 2014-02-18 Irm Llc Compounds and compositions as tlr activity modulators
WO2010070453A2 (en) 2008-12-17 2010-06-24 Novartis Ag Meningococcal vaccines including hemoglobin receptor
US9517263B2 (en) 2009-06-10 2016-12-13 Glaxosmithkline Biologicals Sa Benzonaphthyridine-containing vaccines
EP2470205A1 (en) 2009-08-27 2012-07-04 Novartis AG Adjuvant comprising aluminium, oligonucleotide and polycation
TWI445708B (zh) 2009-09-02 2014-07-21 Irm Llc 作為ｔｌｒ活性調節劑之化合物及組合物
BR112012004806B8 (pt) 2009-09-02 2022-10-04 Novartis Ag composições imunogênicas que incluem moduladores da atividade de tlr, método para aumento da eficácia da referida composição e uso
JP5860402B2 (ja) * 2009-10-08 2016-02-16 イオン メディックス インコーポレイテッド 室内空気由来細胞外ベシクルを含む組成物及びその用途
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
CN102762206A (zh) 2009-12-15 2012-10-31 诺华有限公司 免疫增强化合物的均匀悬液及其用途
CN102802664B (zh) * 2009-12-22 2017-04-05 赛诺菲巴斯德有限公司 免疫原性组合物
WO2012020326A1 (en) 2010-03-18 2012-02-16 Novartis Ag Adjuvanted vaccines for serogroup b meningococcus
EA023725B1 (ru) 2010-03-23 2016-07-29 Новартис Аг Соединения (липопептиды на основе цистеина) и композиции в качестве агонистов tlr2, применяемые для лечения инфекционных, воспалительных, респираторных и других заболеваний
ES2694100T3 (es) 2010-04-07 2018-12-18 California Institute Of Technology Vehículo para distribuir un compuesto en una membrana mucosa y composiciones, procedimientos y sistemas relacionados
AU2011300418B2 (en) * 2010-09-10 2016-05-12 Glaxosmithkline Biologicals Sa Meningococcus overexpressing NadA and/or NHBA and outer membrane vesicles derived therefrom
WO2012153302A1 (en) 2011-05-12 2012-11-15 Novartis Ag Antipyretics to enhance tolerability of vesicle-based vaccines
EP2731617A4 (en) 2011-07-12 2015-07-01 Brigham & Womens Hospital LIPID-BASED PSA COMPOSITIONS, METHOD FOR THEIR INSULATION AND USE METHOD THEREFOR
ES2654613T3 (es) 2012-02-02 2018-02-14 Glaxosmithkline Biologicals Sa Promotores para una expresión aumentada de proteínas en meningococos
JP2015517089A (ja) 2012-03-08 2015-06-18 ノバルティス アーゲー タンパク質ベースの髄膜炎菌ワクチンのためのインビトロ有効性アッセイ
NZ630133A (en) 2012-06-14 2016-10-28 Novartis Ag Vaccines for serogroup x meningococcus
CA2882619A1 (en) 2012-09-06 2014-03-13 Novartis Ag Combination vaccines with serogroup b meningococcus and d/t/p
US11331335B2 (en) 2015-06-10 2022-05-17 California Institute Of Technology Sepsis treatment and related compositions methods and systems
US10857177B2 (en) 2015-08-19 2020-12-08 President And Fellows Of Harvard College Lipidated PSA compositions and methods
US11491181B2 (en) 2016-07-15 2022-11-08 President And Fellows Of Harvard College Glycolipid compositions and methods of use
US12161707B2 (en) 2016-09-02 2024-12-10 Glaxosmithkline Biologicals Sa Vaccines for Neisseria gonorrhoeae
JP2023546665A (ja) * 2020-10-23 2023-11-07 オームヴァックス，インコーポレイテッド． 淋菌（Ｎｅｉｓｓｅｒｉａ Ｇｏｎｏｒｒｈｏｅａｅ）に対するワクチン接種のための組成物及び方法
GB202115077D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Assay

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999003501A1 (en) * 1997-07-17 1999-01-28 North American Vaccine, Inc. Immunogenic conjugates comprising a group b meningococcal porin and an h. influenzae polysaccharide
GB9918319D0 (en) * 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
EP1322328B1 (en) * 2000-07-27 2014-08-20 Children's Hospital & Research Center at Oakland Vaccines for broad spectrum protection against diseases caused by neisseria meningitidis

Also Published As

Publication number Publication date
CN100387298C (zh) 2008-05-14
NZ560766A (en) 2009-09-25
WO2003105890A3 (en) 2004-03-25
MXPA04012568A (es) 2005-09-21
AU2003236734A1 (en) 2003-12-31
WO2003105890A2 (en) 2003-12-24
JP2005531614A (ja) 2005-10-20
PE20040562A1 (es) 2004-10-19
AR040204A1 (es) 2005-03-16
BR0311777A (pt) 2005-03-29
ZA200409547B (en) 2006-07-26
NO20050132L (no) 2005-02-11
UY27843A1 (es) 2003-12-31
CA2488782A1 (en) 2003-12-24
US20060110412A1 (en) 2006-05-25
GB0213622D0 (en) 2002-07-24
EP1565211A2 (en) 2005-08-24
RU2005100509A (ru) 2006-06-10
CL2003001192A1 (es) 2005-01-07
CN1668329A (zh) 2005-09-14
CU23552A1 (es) 2010-07-20
KR20050049431A (ko) 2005-05-25

Similar Documents

Publication Publication Date Title
NO20050132D0 (no) Vaksinesammensetning
IS7806A (is) Ónæmisvaldandi samsetning
ATE553775T1 (de) Impstoffzusammesetzung
IS7547A (is) Ónæmisvaldandi samsetningar
FR2862654B1 (fr) Composition amylacee filmogene
DE10393374D2 (de) Zusammensetzung
DK3536344T3 (da) Superfin formoterolformulering
EP1537195A4 (en) DISINFECTING COMPOSITION
IS8387A (is) Ónæmisvaldandi samsetningar
DK1587478T3 (da) Farmaceutisk sammensætning
IS7831A (is) Bóluefni
DK1561472T3 (da) Faststofsammensætning
IS8309A (is) Lyfjablöndur
DE60320902D1 (de) Zusammensetzungen mit ausgelöster Freisetzung
DK1492934T3 (da) Dørenhed
DE60327447D1 (de) Pflaster
EP1692279A4 (en) VIRUS PREPARATIONS CONTAINING A CONSERVATIVE
SE0500163L (sv) Sammansättning
DE60328408D1 (de) Impfstoff
NO20051561D0 (no) Vaksine
EP1561467A4 (en) COMPOSITION FOR RECOVERING DAMAGED SKIN
IS8325A (is) Bóluefni
PL377147A1 (pl) Doustna kompozycja
NO20044140D0 (no) New Composition
DE60320425D1 (de) Ostertagia-impfstoff

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application